Micro Labs

International Business

Micro is well poised to achieve in the medium term status “BIG GENERIC COMPANY” in the global pharmaceutical space.

The company is building critical mass in existing markets & developing business in new markets like USA, East Europe, North Africa & South America.

The company has marketing and distribution subsidiaries in 28 countries worldwide and exports to about 60 countries.

Highlights

		Presence in 50 countries
		Exporting all major dosage forms in every therapeutic segment
		Corporate offices in ten countries including UK, Thailand, Russia, Vietnam & Ukraine
		Independent marketing operations with fullfledged sales teams
		Focus on ethical promotion (brand building) - sale of branded Generic drugs
		Strategic marketing alliances with local transnational marketing companies
		Site/plant approvals from Health Canada (PICS countries)
		Approved by the MCC South Africa, Health Canada and UK MHRA